Indicaciones y prescripción de la vacuna de la hepatitis A en España. Informe de la Asociación Española para el Estudio del Hígado

Medicina Clinica

Volumn 111, Issue 9, 1998, Pages 341-346

  Bruguera, Miguel ^a   Buti, Maria ^b   Diago, Moisés ^c   Bengoechea, Manuel García ^d   Jara, Paloma ^e   Pedreira, José Domingo ^f   Estremera, Ángela Ruiz ^g  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^d Hospital Nuestra Senora de Aranzazu   (Spain)

^e HOSPITAL INFANTIL LA PAZ   (Spain)

^f HOSPITAL JUAN CANALEJO   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS VACCINE; INACTIVATED VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; COMPARATIVE STUDY; FEMALE; FOOD HANDLING; HEALTH CARE PERSONNEL; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNOLOGY; INCIDENCE; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; RISK FACTOR; SPAIN; VACCINATION; DRUG EFFECT; LIVER DISEASE; PRESCRIPTION; REVIEW; TREATMENT INDICATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOOD HANDLING; HEALTH PERSONNEL; HEPATITIS A; HEPATITIS A VACCINES; HEPATITIS A VIRUS, HUMAN; HEPATOVIRUS; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; RISK FACTORS; SPAIN; VACCINATION; VACCINES, INACTIVATED; VIRAL HEPATITIS VACCINES;

EID: 0032569493     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Salleras L, Bruguera M, Vidal J, Taberner JL, Plans P, Jimenez de Anta MT et al. Cambio del patrón epidemiológico de la hepatitis A en España. Med Clin (Bare) 1992; 99: 87-89.
2. Pérez Trallero E, Cilla G, Urbieta M, Dorronsoro M, Olero F, Marimón JM et al. Falling incidence and prevalence of hepatitis A in northern Spain. Scand J Infect Dis 1994; 26: 133-136.
3. Shapiro CN, Margolis HS. Worldwide epidemiology of hepatitis A virus infection J. Hepatol 1993; 18 (Supl 2): 11-14.
4. Bruguera M, Vidal J, Rodés J. Factures de riesgo en la hepatitis A de los adultos. Gastroenterol Hepatol 1992; 15: 129-133.
5. Koff RS. Seroepidemiology of hepatitis A in the United States. J Infect Dis 1995; 171 (Supl 1): 19-23.
6. Tilzey AJ, Palmer S, Barrow S, Perry KR, Tyrrel H, Safary A et al. Clinical trials with inactivated hepatitis A vaccine and recommendations for its use. Br Med J 1992; 34: 1.272-1.276.
7. Delem A, Salary A, De Namur F, Hauser P, D'Hondt E. Characterization of the immune response of volunteers vaccinated wilti a killed vaccine against hepatitis A. Vaccine 1993; 11: 479-484.
8. Innis BL, Snilbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994; 271: 1.328-1.334.
9. Werzberger A Meusch B, Kuter B, Brocon L, Lewis J, Sitrin R et al. A controlled trial of formalin-inactivated hepatitis A vaccine in healthy chilcren. N Engl J Med 1992; 327: 453-457.
10. De Fraites RF, Freihner BH, Binn LN, Kanjarpane DD, Delem AD. MacArthy PO et al. Immunization of US soldiers with a two-dose primary series of inactivated hepatitis A vaccine: early immune response, persistence of antibody, and response to a third dose at 1 year. J Infect Dis 1995; 171 (Supl 1): 61-69.
11. Green MS, Cohen D, Lerman Y, Sjögren M, Binn LN, Zur S et al. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. J Infect Dis 1993; 168: 740-743.
12. Wiens B, Bohidar N, Pigeon J, Egan J, Hurni W, Brown L et al. Duration of protection from clinical hepatitis A disease after vaccination with VAQTA". J Med Virol 1996; 49: 235-241.
13. Salleras L, Bruguera M, Vidal J, Balalla J, Plans P, Navas E et al. Estralegias de vacunacion antihepatitis B en Cataluna. Gastroenterol Hepatol 1993; 16: 140-146.
14. Dobson S, Scheifele D, Bell A. Assessment of universal school-based hepatitis B vaccination program JAMA 1995; 274: 1.209-1.213.
15. Desenclos JC, McLafferty L. Community wide outbreak of hepatitis A linked to children in day care centers and with increased transmission in young adults men in Florida 1988-1989. J Epidemiol Community Health 1993; 47: 269-273.
16. Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS. Epidemiology of hepatitis A: seroepidemiology at risk groups in the USA. Vaccine 1992; 10 (Supl 1): 59-62.
17. Navas E, Bayas JM, Bruguera M, Vidal J, Gali N, Taberner JL et al. Eficiencia de la deteoccion prevacunal do anti-VHA en los programas de vacunación antihepatitis A. Med Clin (Bare) 1995; 105: 168-171.
18. Steffen R. Risk of hepatitis A in travellers. Vaccine 1992; 10 (Supl 1): 69-72.
19. Wolfe MS. Hepatitis A and the American traveller J Infect Dis 1995; 171 (Supl 1): 29-32.
20. Steffen R. Hepatitis A in travellers: the European experience. J Infect Dis 1995; 171 (Sup 1): 24-28.
21. Aronson N, Palmer BF. Acute viral hepatitis in American soldiers in Korea South Med J 1988; 81: 949-951
22. Bancroft WH, Lemon SM. Hepatitis A torm the military perspective. En: Gerety RJ, editor. Hepatitis A. Orlando: Academic Press, 1984: 81-100.
23. Hoke SH, Binn LN, Egan JE, De Fraites RF, McArthy Po, Innis BL etal. Hepatitis A in the US army: epidemiology and vaccine development. Vaccine 1992; 10 (Supl 1): 75-79.
24. Morbidity and Mortality Weekly Report. Hepatitis A among persons with hemophilia who received clotting factor concentrate-United States. MMWR 1996; 45: 29-32.
25. Hadler SC, Webster HM, Esben JJ, Swanson JE, Maynard JE. Hepatitis A in day care centers. A community-wide assessment. N Engl J Med 1980; 302: 1.222-1.227.
26. Hadler SC, Esben JJ, Francis DP, Webster HM, Maynard JE. Risk factors for hepatitis A in day-care centers. J Infect Dis 1982; 145: 255-261.
27. Skinhoj P, Hollinger FB, Hovind-Hongen K, Lous P. Infectious liver diseases in three groups of Copenhagen workers: correlation of hepatitis A infection to sewage exposure. Arch Environ Health 1981; 36: 139-143.
28. Poole CJM, Shakespeare TE. Should sewage workors and carers for people with learning disabilities be vaccinated for hepatitis A? Br Med J 1993; 306: 1.102.
29. Henning KJ, Bell E, Brann J, Baske ND. A community-wide outbreak of hepatitis A: risk factors for infection among homosexual and bisexual men. Am J Med 1995; 99: 132-136.
30. Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine 1992; 10 (Supl 1): 59-62.
31. Corey L, Holmes KK. Sexual transmission of hepatitis A in homosexual men. N Engl J Med 1979; 302: 435-438.
32. Harkess J, Gildon B, Istre GR. Outbreaks of hepatitis A among illicit drug users, Oklahoma 1984-1987. Am J Pub Health 1989; 79: 463-466.
33. CDC. Hepatitis A among drug abusers. MMWR 1988; 37: 297-300, 305.
34. Kashiwagi S, Hayashi J, Ikematsn H. Prevalence of immunologie markers of hepatitis A and B infection in hospital personnes in Miyazaki Prefecture, Japan. Am J Epidemiol 1985; 122: 960-969.
35. Drusin LM, Sohmer M, Groshen SL, Spiritos MD, Senterfit LB, Christenseno WN. Nosocomial hepatitis A infection in a pediatric intensive care unil. Arch Dis Child 1987; 62: 690-695.
36. Carl M, Francis DP, Maynard JE. Food-borne hepatitis A: recomendations for control. J Infect Dis 1993, 148: 1.133-1.135.
37. Dienstag JL, Routenberg J, Purcell RH, Hooper R. Foodhandler-associated outbreak of hepatitis A. Ann Intern Med 1975; 83: 647-650.
38. Rosenblum LS, Mirkin IR, Allen DT. A multifocal outbreak of hepatitis A traced to commercially distributed latuce. Am J Public Health 1990; 80: 1.075-1.079.
39. Keeffe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other liver diseases? Am J Gastroenterol 1995; 90: 201-205.
40. McMahon BJ, Belter M, Williams J, Schloos M, Tanttila H, Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated A vaccine. Arch Pediatr Adolesc Med 1996; 150: 733-739.
41. Ministerio de Sanidad y Consumo. Dirección General de Farmacia y Productos Samtarios. Circular 12/97. Vacuna hepatitis A.
42. Ministerio de Sanidad y Consumo. Direcdon General de Farmacia y Productos Sanitarios. Circular 13/97. Vacuna combinada contra la hepatitis AyB.